Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| SELECT MEDICAL HOLDINGS CORPSEM · Entity 33845 | Director | August 01, 2023 | August 02, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
SELECT MEDICAL HOLDINGS CORP
Report date August 01, 2023 · Filed August 02, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 75,035 |
Reported balance
After 2023-08-01 transaction · row 1
1 source rowRow 1 · 2023-08-01 · Grant · Acquired 216 · Balance 75,035 F1: The grant of restricted stock was issued to the reporting person pursuant to the Select Medical Holdings Corporation 2020 Equity Incentive Plan in lieu of a pro-rated quarterly retainer of $18,000. |
| Common StockSEC Table I · non-derivative | IndirectBy the Bryan Cressey and Iliana Sweis Cressey Foundation | 70,000 |
Reported balance
Holding disclosure · report date 2023-08-01 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 70,000 F2: The reporting person beneficially owns the shares indirectly, but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. |
| Common StockSEC Table I · non-derivative | IndirectBy Cressey Investments LLC | 383,850 |
Reported balance
Holding disclosure · report date 2023-08-01 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 383,850 F3: The reporting person beneficially owns the shares indirectly, but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: The grant of restricted stock was issued to the reporting person pursuant to the Select Medical Holdings Corporation 2020 Equity Incentive Plan in lieu of a pro-rated quarterly retainer of $18,000.
F2: The reporting person beneficially owns the shares indirectly, but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
F3: The reporting person beneficially owns the shares indirectly, but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
BELDEN INC.
Report date May 25, 2022 · Filed May 27, 2022
Section 16 reporting ended · disclosed 2022-05-27. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 11,133 |
Reported balance
After 2022-05-25 transaction · row 1
1 source rowRow 1 · 2022-05-25 · Grant · Acquired 2,655 · Balance 11,133 F1: Grant of shares under the Company's 2021 Long Term Incentive Plan. Based on value of $145,000 divided by the closing price of Belden stock on May 25, 2022 ($54.61). |
| Common StockSEC Table I · non-derivative | IndirectInvestment LLC | 194,211 |
Reported balance
Holding disclosure · report date 2022-05-25 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 194,211 |
Filing footnotes · ownership attribution and instrument terms
F1: Grant of shares under the Company's 2021 Long Term Incentive Plan. Based on value of $145,000 divided by the closing price of Belden stock on May 25, 2022 ($54.61).
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 02, 2017 Filed Aug 4, 2017 16:48 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | GrantCommon Stock | 1,139 | $15.80 | $17,996.20 |
DisclosureSEC source: 0001179110-17-011139 · edgar.xml · nonDerivative · entry 2 CRESSEY BRYAN C · CIK 0001072745 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 623,294 F2 · shares: This grant of restricted stock was issued to the reporting person pursuant to the Select Medical Holdings Corporation 2016 Equity Incentive Plan in lieu of a quarterly retainer of $18,000. Read SEC document |
| August 02, 2017 Filed Aug 4, 2017 16:48 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | GrantCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-011139 · edgar.xml · nonDerivative · entry 1 CRESSEY BRYAN C · CIK 0001072745 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 622,155 F1 · shares: Grant of restricted stock which, subject to certain exceptions, will vest in full on August 2, 2018, the first anniversary of the grant date. Read SEC document |
| May 26, 2017 Filed May 31, 2017 19:04 UTC | BELDEN INC. BDC · Entity 4002 | GrantCommon Stock | 2,403 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-036380 · doc4.xml · nonDerivative · entry 1 CRESSEY BRYAN C · CIK 0001072745 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 186,925 F1 · shares: Grant of Restricted Stock Units (RSUs) under the Company's 2011 Long Term Incentive Plan. Based on value of $168,900 divided by the closing price on the grant date, May 26, 2017 ($70.30). RSUs generally vest one year after the date of award, but are subject to accelerated vesting under certain circumstances, including death, disability and retirement. Read SEC document |
| May 03, 2017 Filed May 4, 2017 18:07 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | GrantCommon Stock | 1,319 | $13.65 | $18,004.35 |
DisclosureSEC source: 0001179110-17-006591 · edgar.xml · nonDerivative · entry 1 CRESSEY BRYAN C · CIK 0001072745 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 612,155 F1 · shares: This grant of restricted stock was issued to the reporting person pursuant to the Select Medical Holdings Corporation 2016 Equity Incentive Plan in lieu of a quarterly retainer of $18,000. Read SEC document |
| February 16, 2017 Filed Feb 17, 2017 16:42 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | GrantCommon Stock | 1,401 | $12.85 | $18,002.85 |
DisclosureSEC source: 0001179110-17-002668 · edgar.xml · nonDerivative · entry 1 CRESSEY BRYAN C · CIK 0001072745 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 610,836 F1 · shares: This grant of restricted stock was issued to the reporting person pursuant to the Select Medical Holdings Corporation 2016 Equity Incentive Plan in lieu of a quarterly retainer of $18,000. Read SEC document |
| November 02, 2016 Filed Nov 3, 2016 16:51 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | GrantCommon Stock | 1,475 | $12.20 | $17,995.00 |
DisclosureSEC source: 0001179110-16-031157 · edgar.xml · nonDerivative · entry 1 CRESSEY BRYAN C · CIK 0001072745 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 609,435 F1 · shares: This grant of restricted stock was issued to the reporting person pursuant to the Select Medical Holdings Corporation 2016 Equity Incentive Plan in lieu of a quarterly retainer of $18,000. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.